Olympus Innovation Ventures

Medical Technologies

Olympus Innovation Ventures Adds Prostate Care Platform Developer to its Portfolio

Olympus Innovation Ventures (OIV), the venture capital arm of Olympus Corp., recently announced a new portfolio pick. OIV is one of four investors in Series A funding to support MaxQ Medical, Inc., a Sunnyvale, Calif.-based startup developing an all-in-one transurethral imaging and therapy system for prostate care.

Research Round-Up

Olympus Innovation Ventures: Charting the Course for Medtech Breakthroughs in 2026 and Beyond

The venture capital arm of Olympus Corp. recently announced its next phase of funding since its launch in 2021: A 10-year, $150 million investment in future medtech endeavors. How will this next round of portfolio picks take shape based on previous experience and new corporate strategy?

Medical Technologies

AI Integrated Wearables for Gut Health Diagnosis: Olympus Innovation Ventures Invests in Alimetry

The clinician-founded team behind Alimetry recently announced the close of their Series A2 round of funding to pursue broad commercialization of their AI-powered, wearable device. The Alimetry device is designed to be used as an aid in the diagnosis of gut disorders that have proven difficult to solve using conventional diagnostics and testing.

Medical Technologies

A Patient-first Approach to Improve Bladder Control: Olympus Innovation Ventures Invests in Neuspera

Olympus Innovation Ventures (OIV) recently announced a Series D investment in Neuspera Medical, Inc. This move underscores OIV’s commitment to investing in pioneering minimally invasive solutions that have the potential to enhance patient care and quality of life.

INVESTOR INFORMATION